Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Revenue
Glenmark Life Sciences Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Revenue
₹21.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Revenue
₹272.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Revenue
₹253.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Revenue
₹474.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Revenue
₹186.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Revenue
₹87.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Glenmark Life Sciences Ltd's Revenue?
Revenue
21.6B
INR
Based on the financial report for Mar 31, 2023, Glenmark Life Sciences Ltd's Revenue amounts to 21.6B INR.
What is Glenmark Life Sciences Ltd's Revenue growth rate?
Revenue CAGR 3Y
12%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Glenmark Life Sciences Ltd have been 12% over the past three years .